Search - tctmd.com

Displaying 461 - 480 of 603

Sort: Relevancy | Date

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Daily News

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

Yael L. Maxwell

October 10, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Yael L. Maxwell

September 02, 2019

News Daily News

Decline in US Deaths From CVD and Diabetes Is Leveling Off

Todd Neale

August 27, 2019

News Daily News

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Yael L. Maxwell

August 14, 2019

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Todd Neale

July 24, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News SCCT 2019

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Yael L. Maxwell

July 23, 2019

News Daily News

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Marcus A. Banks

July 22, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Yael L. Maxwell

July 04, 2019

News Daily News

Weight Gain After Smoking Cessation: No Link With Increased CVD Risk in Young People

L.A. McKeown

June 27, 2019

News Daily News

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

L.A. McKeown

June 25, 2019

News Conference News EAS 2019

Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis

Michael O'Riordan

May 28, 2019

Advertisement

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Walk and Talk: Step-Counting Devices Work Best When Paired With Doctor Consults

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Decline in US Deaths From CVD and Diabetes Is Leveling Off

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Microvascular Disease Quadruples Risk of Leg Amputation

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Weight Gain After Smoking Cessation: No Link With Increased CVD Risk in Young People

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content